Phase I Study of Glesatinib (MGCD265) in Combination with Erlotinib or Docetaxel in Patients with Advanced Solid Tumors.
Amita PatnaikShirish GadgeelKyriakos P PapadopoulosDrew W RascoNaomi B HaasHirak Der-TorossianDemiana FaltaosDiane PotvinVanessa TassellManal TawashiRichard ChaoPeter J O'DwyerPublished in: Targeted oncology (2022)
ClinicalTrials.gov NCT00975767; 11 September 2009.
Keyphrases